These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 28719220)

  • 1. EGFR-Targeted Cationic Polymeric Mixed Micelles for Codelivery of Gemcitabine and miR-205 for Treating Advanced Pancreatic Cancer.
    Mondal G; Almawash S; Chaudhary AK; Mahato RI
    Mol Pharm; 2017 Sep; 14(9):3121-3133. PubMed ID: 28719220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR-Targeted Polymeric Mixed Micelles Carrying Gemcitabine for Treating Pancreatic Cancer.
    Mondal G; Kumar V; Shukla SK; Singh PK; Mahato RI
    Biomacromolecules; 2016 Jan; 17(1):301-13. PubMed ID: 26626700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.
    Chaudhary AK; Mondal G; Kumar V; Kattel K; Mahato RI
    Cancer Lett; 2017 Aug; 402():1-8. PubMed ID: 28536008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micelle Mixtures for Coadministration of Gemcitabine and GDC-0449 To Treat Pancreatic Cancer.
    Karaca M; Dutta R; Ozsoy Y; Mahato RI
    Mol Pharm; 2016 Jun; 13(6):1822-32. PubMed ID: 26981724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodistribution of Self-Assembling Polymer-Gemcitabine Conjugate after Systemic Administration into Orthotopic Pancreatic Tumor Bearing Mice.
    Kattel K; Mondal G; Lin F; Kumar V; Mahato RI
    Mol Pharm; 2017 May; 14(5):1365-1372. PubMed ID: 27798825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Codelivery of small molecule hedgehog inhibitor and miRNA for treating pancreatic cancer.
    Kumar V; Mondal G; Slavik P; Rachagani S; Batra SK; Mahato RI
    Mol Pharm; 2015 Apr; 12(4):1289-98. PubMed ID: 25679326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GEM-loaded magnetic albumin nanospheres modified with cetuximab for simultaneous targeting, magnetic resonance imaging, and double-targeted thermochemotherapy of pancreatic cancer cells.
    Wang L; An Y; Yuan C; Zhang H; Liang C; Ding F; Gao Q; Zhang D
    Int J Nanomedicine; 2015; 10():2507-19. PubMed ID: 25848268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox-responsive nanoplatform for codelivery of miR-519c and gemcitabine for pancreatic cancer therapy.
    Xin X; Kumar V; Lin F; Kumar V; Bhattarai R; Bhatt VR; Tan C; Mahato RI
    Sci Adv; 2020 Nov; 6(46):. PubMed ID: 33177098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of gemcitabine conjugated and miRNA-205 complexed micelles for treatment of advanced pancreatic cancer.
    Mittal A; Chitkara D; Behrman SW; Mahato RI
    Biomaterials; 2014 Aug; 35(25):7077-87. PubMed ID: 24836307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR-targeted gelatin nanoparticles for systemic administration of gemcitabine in an orthotopic pancreatic cancer model.
    Singh A; Xu J; Mattheolabakis G; Amiji M
    Nanomedicine; 2016 Apr; 12(3):589-600. PubMed ID: 26656632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer cell membrane-modified Soluplus® micelles for gemcitabine delivery to pancreatic cancer using a prodrug approach.
    Pereira-Silva M; Diaz-Gomez L; Blanco-Fernandez B; Ferreirós A; Veiga F; Concheiro A; Paiva-Santos AC; Alvarez-Lorenzo C
    Int J Pharm; 2024 Sep; 662():124529. PubMed ID: 39084580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemcitabine-Lipid Conjugate and ONC201 Combination Therapy Effectively Treats Orthotopic Pancreatic Tumor-Bearing Mice.
    Shrestha P; Ghanwatkar Y; Mahto S; Pramanik N; Mahato RI
    ACS Appl Mater Interfaces; 2024 Jun; 16(23):29686-29698. PubMed ID: 38813771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro.
    Elechalawar CK; Hossen MN; Shankarappa P; Peer CJ; Figg WD; Robertson JD; Bhattacharya R; Mukherjee P
    Int J Nanomedicine; 2020; 15():991-1003. PubMed ID: 32103952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of pancreatic cancer xenografts with Erbitux (IMC-C225) anti-EGFR antibody, gemcitabine, and radiation.
    Buchsbaum DJ; Bonner JA; Grizzle WE; Stackhouse MA; Carpenter M; Hicklin DJ; Bohlen P; Raisch KP
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(4):1180-93. PubMed ID: 12419447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.
    Bruns CJ; Harbison MT; Davis DW; Portera CA; Tsan R; McConkey DJ; Evans DB; Abbruzzese JL; Hicklin DJ; Radinsky R
    Clin Cancer Res; 2000 May; 6(5):1936-48. PubMed ID: 10815919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth in Pancreatic Cancer.
    Ray P; Dutta D; Haque I; Nair G; Mohammed J; Parmer M; Kale N; Orr M; Jain P; Banerjee S; Reindl KM; Mallik S; Kambhampati S; Banerjee SK; Quadir M
    Mol Pharm; 2021 Jan; 18(1):87-100. PubMed ID: 33231464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-delivery of gemcitabine and cisplatin via Poly (L-glutamic acid)-g-methoxy poly (ethylene glycol) micelle to improve the in vivo stability and antitumor effect.
    Ding N; Zhao Z; Yin N; Xu Y; Yin T; Gou J; He H; Wang Y; Zhang Y; Tang X
    Pharm Res; 2021 Dec; 38(12):2091-2108. PubMed ID: 34893950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-assembling, amphiphilic polymer-gemcitabine conjugate shows enhanced antitumor efficacy against human pancreatic adenocarcinoma.
    Chitkara D; Mittal A; Behrman SW; Kumar N; Mahato RI
    Bioconjug Chem; 2013 Jul; 24(7):1161-73. PubMed ID: 23758084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEG-b-poly (carbonate)-derived nanocarrier platform with pH-responsive properties for pancreatic cancer combination therapy.
    Ray P; Confeld M; Borowicz P; Wang T; Mallik S; Quadir M
    Colloids Surf B Biointerfaces; 2019 Feb; 174():126-135. PubMed ID: 30447521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coadministration of Polymeric Conjugates of Docetaxel and Cyclopamine Synergistically Inhibits Orthotopic Pancreatic Cancer Growth and Metastasis.
    Almawash SA; Mondal G; Mahato RI
    Pharm Res; 2018 Jan; 35(1):17. PubMed ID: 29305793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.